DexCom, Inc. vs MasterCard Inc — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while MasterCard Inc trades at $559.6 (market cap $493.34B). The key difference: MasterCard Inc is far larger — about 14.9× DexCom, Inc.'s market cap, and MasterCard Inc pays a 0.62% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | MA | |
|---|---|---|
Market Cap | $33.08B | $493.34B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $598.96 |
52-Week Low | $54.84 | $471.55 |
Enterprise Value | $32.53B | $506.38B |
Volume | — | 4,635,698 |
Dividend Yield | — | 0.62% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mastercard (MA) trades at $563.17, up 0.04% today, with a bullish technical signal and strong institutional buying. The stock shows robust fundamentals, with revenue growing from $22.2B in 2022 to $32.8B in 2025 and net income margins above 45%. Recent earnings beats and a consensus price target of $660.85 reflect optimism, though high valuation ratios like a P/E of 30.98 warrant caution.
Outlook is positive due to consistent earnings growth, expanding digital payment initiatives, and analyst buy ratings. Risks include competitive pressures from new payment technologies and regulatory scrutiny. The stock offers upside potential but requires monitoring of valuation and market shifts.
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →